EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics

Leon M Larcher, Ianthe L Pitout, Niall P Keegan, Rakesh N Veedu, Sue Fletcher iD

Nucleic Acid Therapeutics · 01.06.2023 · 33 (3) · 178-192

DOI: 10.1089/nat.2022.0066 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nucleic Acid Therapeutics, online erschienen am 02.06.2023. Verfasst von Leon M Larcher und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, Australia. Hauptthemen laut MEDLINE: DNA, Catalytic. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleic acids drugs have been proven in the clinic as a powerful modality to treat inherited and acquired diseases. However, key challenges including drug stability, renal clearance, cellular uptake, and movement across biological barriers (foremost the blood–brain barrier) limit the translation and clinical efficacy of nucleic acid–based therapies, both systemically and in the central nervous system. In this study we provide an overview of an emerging class of nucleic acid therapeutic, called DNAzymes. In particular, we review the use of chemical modifications and carrier molecules for the stabilization and/or delivery of DNAzymes in cell and animal models. Although this review focuses on DNAzymes, the strategies described are broadly applicable to most nucleic acid technologies. This review should serve as a general guide for selecting chemical modifications to improve the therapeutic performance of DNAzymes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, CatalyticAnimalsRNA

Stichwörter der Autor:innen

DNA catalystDNAzymecentral nervous systemdeliverynucleic acidstherapeutics molecular medicines

Substanzen

DNA, CatalyticRNA

Autor:innen und Institutionen

  • Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, Australia.
  • Discovery, PYC Therapeutics, Nedlands, Australia.
  • Precision Nucleic Acid Therapeutics, Perron Institute for Neurological and Translational Science, Perth, Australia.

ORCID-Profile: Sue Fletcher

Zitieren

APA

Larcher, L. M., Pitout, I. L., Keegan, N. P., Veedu, R. N., & Fletcher, S. (2023). DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics. Nucleic Acid Therapeutics, 33(3), 178-192. https://doi.org/10.1089/nat.2022.0066

Vancouver

Larcher LM, Pitout IL, Keegan NP, Veedu RN, Fletcher S. DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics. Nucleic Acid Therapeutics. 2023;33(3):178-192. doi:10.1089/nat.2022.0066

BibTeX
@article{Larcher2023,
  author = {Larcher, Leon M and Pitout, Ianthe L and Keegan, Niall P and Veedu, Rakesh N and Fletcher, Sue},
  title = {DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics},
  journal = {Nucleic Acid Therapeutics},
  year = {2023},
  volume = {33},
  number = {3},
  pages = {178--192},
  doi = {10.1089/nat.2022.0066}
}
Kostenlos starten →